1. Home
  2. SPRB

SPRB

Spruce Biosciences Inc.

Logo Spruce Biosciences Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

Founded: 2014 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 30.3M IPO Year: 2020
Target Price: $3.60 AVG Volume (30 days): 1.3M
Analyst Decision: Hold Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.24 EPS Growth: N/A
52 Week Low/High: $0.68 - $5.95 Next Earning Date: 05-13-2024
Revenue: $10,089,000 Revenue Growth: N/A
Revenue Growth (this year): -53.44% Revenue Growth (next year): -45.71%

Share on Social Networks: